Health Condition 1: N926- Irregular menstruation, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Women of reproductive age group 18-45years Patients with symptoms of heavy and prolonged menstrual bleeding or intermenstrual bleeding Patients willing for trial will be selected Patient with simple ovarian cyst
Exclusion criteria
Exclusion criteria: Patients with any diagnosed uterine organic pathology like Uterine Fibroid, ChronicTubo-ovarian mass. Patients with systemic diseases like hypertension, diabetes mellitus, congestive cardiac failure etc. Patients with coagulopathy, liver and thyroid dysfunction etc. Patients with malignancy or undiagnosed neoplasm. Patients with history of recent abortion. Patients with active genital tuberculosis Pregnant and Lactating women. IUCD in utero, pelvic endometriosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the clinical efficacy of combination of Amarsundari vati with Chandanbala taila Matra basti for treating heavy and/ or prolonged menstrual bleeding or intermenstrual bleeding in terms of amount of menstrual blood loss in cases of Asrigdar (Menorrhagia)Timepoint: To evaluate the clinical efficacy of combination of Amarsundari vati with Chandanbala taila Matra basti for treating heavy and/ or prolonged menstrual bleeding or intermenstrual bleeding in terms of amount of menstrual blood loss in cases of Asrigdara (Menorrhagia) | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the clinical efficacy of the drug on the change in endometrial thickness & improvement in haemoglobin levelTimepoint: To evaluate the clinical efficacy of the drug on the change in endometrial thickness & improvement in haemoglobin level | — |
Countries
India
Contacts
All India Institute Of Ayurveda Gautampuri Sarita vihar New Delhi 110076 South Delhi